This site requires Javascript.

Please enable Javascript before proceeding:

Firefox

  1. In the FireFox address bar, type about:config.
  2. Look for the javascript.enabled setting.
  3. Set it to true by right-clicking and pressing toggle.

Internet Explorer

  1. On the Tools menu, click Internet Options, then click the Security tab.
  2. Click the Internet Zone.
  3. If you do not have to customize your Internet security settings, click Default Level. Then do step 4.
  4. If you have to customize your Internet security settings, follow these steps:
    a. Click Custom Level.
    b. In the Security Settings - Internet Zone dialog box, click Enable for Active Scripting in the Scripting section.
  5. Click the Back button to return to the previous page, and then click the Refresh button to run scripts.

Chrome

  1. In the Chrome address bar, type chrome://settings/content/javascript.
  2. Adjust the toggle so that javascript is allowed.
  3. Close the Settings tab and Refresh the page.

 

Welcome

Princess Margaret Hematology Conference (PMHC)
March 26-28, 2026, Courtyard Marriott Downtown

The Princess Margaret Hematology Conference (PMHC), held in collaboration with the International Lymphoma Radiation Oncology Group (ILROG), is a landmark inaugural event within the Malignant Hematology Program at the Princess Margaret Cancer Centre, one of the world’s leading cancer research and treatment institutions. This prestigious conference is designed to foster collaboration, innovation, and knowledge exchange among national and international experts, researchers, clinicians, and other professionals dedicated to advancing the field of hematologic malignancies, including leukemia, lymphoma, myeloma, and related disorders as well as the recent developments in allogeneic/ autologous hematopoietic stem cell transplantation and immune cellular therapy for the treatment of hematologic cancers.

This is a two and a half day scientific forum which aims to serve as a premier platform for discussing the latest advancements in clinical and basic research, as well as the development of cutting-edge clinical studies in hematologic cancers. By bringing together a diverse group of stakeholders—renowned oncologists, hematologists, radiation oncologists, researchers, translational scientists, and allied health professionals—the conference will facilitate interdisciplinary dialogue to address the most pressing challenges and opportunities in the field. This includes keynote speakers, plenary and breakout sessions, poster presentations, debate and networking opportunities at the welcome reception. 

The conference overall objectives are to:

  • Present the latest breakthroughs in the understanding, diagnosis, and treatment of hematologic malignancies, including novel therapies, precision medicine, and immunotherapy.
  • Create opportunities for networking and collaboration among global leaders to drive innovative clinical trials and research initiatives.
  • Provide updates on evidence-based practices, emerging technologies, and multidisciplinary approaches to improve patient outcomes.
  • Offer a platform for early-career researchers and clinicians to present their work, engage with experts, and contribute to the field’s future.
Register
Returning Registrant

Event Dates & Times

Thursday March 26, 2026
8:00 am - 5:30 pm EDT

Friday March 27, 2026
7:30 am - 5:30 pm EDT

Saturday March 28, 2026
8:00 am - 1:30 pm EDT

Event Location

Courtyard Toronto Downtown Hotel
475 Yonge St,
Toronto, ON
M4Y 1X7

Key Dates

December 16th:
Registration Opens

December 16th:
Call for Abstracts Opens

January 26th:
Deadline for Abstract Submission

End of February:
Abstract Results

Information & Assistance

Conference Services
conferences@uhn.ca